Moonwalk Biosciences
Last verified 2026-06-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $57.0Mattributed |
|---|---|
| Latest round | series-a, $57.0M, 2024-01-01attributed |
| Founded | 2023 |
| Headquarters | South San Francisco, US |
| Industry | bio |
| Stage | series-a |
| Website | moonwalk.bio |
Moonwalk Biosciences develops therapies that target the molecular regulation of fat tissue using genetic and epigenetic insights, with a focus shifting toward siRNA obesity treatments. It serves patients with obesity and cardiometabolic conditions.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | series-a | $57.0M | gv |
Detected tech stack
all in one seo pro 4.9.7.2, complianz, doubleclick floodlight, dynamic conditions 1.7.5, elementor 4.1.0, fastly, font awesome, google analytics, google tag manager, hsts, imagesloaded 5.0.0, jquery 3.7.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $57.0M | attributed | vc-portfolio named as publisher. No document URL on file. |
| Total raised $57.0M | attributed | vc-portfolio named as publisher. No document URL on file. |
| Company existence | self-reported | moonwalk.bio, read 2026-06-02 |
| Description | self-reported | moonwalk.bio, read 2026-06-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.